Adolescent patients with mild-to-moderate emotional disorders accompanied by attention decline
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age: 12–18 years (inclusive), both genders; 2.Meet the diagnostic criteria for anxiety disorders or depressive disorders in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). 3.Hamilton Depression Rating Scale-17 (HAMD-17) > 7 or Hamilton Anxiety Rating Scale (HAMA) > 7; 4.Able to cooperate and complete the entire study; 5.Both the subject and their guardian are willing to sign the informed consent form to participate in this study;
Exclusion criteria
Exclusion criteria: 1.Patients with severe depression (with obvious suicidal tendency); 2.Patients with neuropsychiatric disorders such as intellectual disability, schizophrenia, or history of epilepsy; 3.Patients with suspected intellectual disability; 4.Patients with a history of alcohol or substance abuse; 5.Patients who have used traditional Chinese medicine for anti-anxiety, anti-depression, or sleep assistance within the past two weeks; 6.Patients who have taken benzodiazepines or azapirone drugs within the past week. 7.Patients deemed unsuitable for enrollment by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The measurement of attention span at the end of the 6th week of treatment, the error rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The Hamilton Depression Rating Scale - 17 scores at the 2nd and 6th weeks of treatment;The attention span measurement conducted at the 6th week of treatment;The Hamilton Anxiety Scale scores at the 2nd and 6th weeks of treatment;Comparison of the differences in SDQ scores at the 2nd and 6th weeks of treatment compared to the baseline values; | — |
Countries
China
Contacts
Huzhou Third Municipal Hospital